Undergoing tests is a critical step in the process of transforming an innovative design into a reliable and marketable product
A medical device or material that comes in contact with the patient's body is expected to perform its intended function without resulting in any adverse effect to a patient. Potential adverse effects can range from short-term (acute) to long-term (chronic) adverse effects to the body such as mutagenic effects. For this reason, medical devices are typically subject to biological evaluation and biocompatibility testing to evaluate the interaction between a device and tissue, cells or body fluids of the patient. The primary purpose of a device biocompatibility assessment is to protect patient from potential biological risks.
ISO 10993-1, Biological Evaluation of Medical Devices - Part 1: Evaluation and Testing within a Risk Management Process provides a framework for determining the appropriate biocompatibility steps for planning a biological evaluation. Specific testing is dependent on the type of medical device or material and its intended use, and on the nature and duration of contact between the medical device and the body. According to the standard, an assessment for biological effects from the exposure of a medical device or material to human body can include testing such as cytotoxicity, sensitization, irritation or intracutaneous reactivity, systemic toxicity, subchronic toxicity, genotoxicity, implantation and haemocompatibility, etc.
Biocompatibility testing shall be conducted in compliance with Principles of Good Laboratory Practice (GLP) and/or ISO/IEC 17025.
TÜV SÜD offers a comprehensive range of biocompatibility testing services according to the ISO 10993 series of standards, including biocompatibility studies and chemical-related testing services. In addition, TÜV SÜD Product Service’s industry specialists and clinical practitioners have extensive experience with all types of medical devices, and the compliance of regulatory requirements for medical devices in major medical device markets.
Ensure the continued recognition of previously approved medical devices that incorporate Tyvek®.
Overcoming hazards in connected healthcare
Transforming the way we track, manage and improve our health
Select Your Location
Bosnia and Herzegovina